Introduction nomenon originally described as cross-priming (Bevan, 1976) . Recent studies have demonstrated that profes-CD8 T lymphocytes recognize infected cells which dissional antigen-presenting cells (APC) such as macroplay pathogen-derived peptides bound to cell surface phages are responsible for processing and presenting major histocompatibility complex (MHC) class I moleexogenous antigens to CD8 T cells (reviewed by Jondal cules (York and Rock, 1996) . Upon recognition, CD8 T et al., 1996) . In vitro experiments suggest at least two cells express a variety of effector functions, including routes for presentation of exogenous antigens: a cytosol killing of infected target cells and secretion of interdependent pathway involving translocation of the exogferon-␥ (IFN␥). CD8 cytotoxic T lymphocytes (CTL) play enous antigen from the phagosome to the cytoplasm a major role in protective immunity against viruses as (Kovacsovics and Rock, 1995) , and a cytosol indepenwell as intracellular bacteria (Kaufmann, 1993 ; Ahmed dent pathway involving peptide loading of MHC class I and Gray, 1996) . Unlike viruses with limited genome size, molecules targeted to vacuoles containing degraded bacteria have the coding capacity to produce thousands antigen (Jondal et al., 1996) or regurgitation of the reof distinct proteins that are sorted into different bacterial sulting peptides to bind surface MHC class I molecules compartments. Bacterial pathogens thus provide a com- (Pfeifer et al., 1993) . It is assumed that one or both plex array of potential targets for recognition by CD8 T of these pathways account for priming of CD8 T cell responses to exogenous antigens in vivo. The efficiency of exogenous MHC class I antigen presentation path- § To whom correspondence should be addressed.
ways and their contribution to immunity against infection are currently unknown.
Proteins secreted by intracellular LM into the host cell cytosol are readily accessible to the endogenous MHC class I antigen processing pathway. Three CD8 T cell epitopes have been identified from secreted proteins of LM (Pamer et al., 1991; Vijh and Pamer, 1997) , and CTL specific to two of these epitopes provide significant immunity to LM infection (Harty and Bevan, 1992; Harty and Pamer, 1995) . In contrast, no CD8 T cell epitopes from nonsecreted LM proteins have been described. However, a study (Schafer et al., 1992) has demonstrated the induction of CD8 T cells against ␤-galactosidase, which was expressed but not specifically targeted for secretion in LM. During LM infection, many bacteria are killed in the phagosome of activated macrophages (North, 1970; Portnoy et al., 1989; de Chastellier and Berche, 1994) . After bacterial lysis, nonsecreted proteins become available for presentation by the exogenous MHC class I pathways that originate in the phagosome.
In this study, we have examined the effect of bacterial antigen compartmentalization on in vivo priming of CD8 T cells and protective immunity against bacterial infection. Our results show that recombinant LM (rLM) strains expressing either a secreted or nonsecreted form of a model CD8 T cell epitope can efficiently induce epitopespecific CD8 T cell responses. However, epitope-specific memory CD8 T cells confer protection only against rLM secreting the epitope but not against rLM expressing the nonsecreted epitope. Thus, bacterial antigen compartmentalization has differential impact on in vivo (A) Diagram of antigen cassettes integrated into the bacterial genome at a specific site between two convergent transcriptional units, lecithinase operon and lactate dehydrogenase (LDH) operon, and
Results
downstream from a putative transcriptional terminator. HSL235 and HSL236 express a HlyЈ-PhoA fusion without or with the LCMV NP
Isogenic Strains of rLM Expressing a Model
118-126 epitope and serve as a negative and positive control, respectively. XFL303 and XFL304 are a pair of isogenic strains that
CD8 T Cell Epitope in a Secreted
express a fusion protein consisting of the NP 118-126 epitope-fused or Nonsecreted Fusion Protein to DHFR, monoclonal antibody epitopes (ha and vg), and sequences Quantitative analysis of the impact of antigen compartcontaining the hly promoter (Phly), the translation start codon (M) mentalization on immunogenicity requires a direct comwith the signal sequence (SS) in XFL303 and without the signal parison of the same antigen that is expressed in different sequence in XFL304. The signal sequence in XFL303 contains five bacterial compartments. We have previously described Hly residues downstream from the cleavage site to ensure efficient cleavage and secretion. All antigen cassettes carry a kanamycin a genetic system for expression and secretion of heterolresistance marker (Aph-A3).
ogous antigens by rLM, based on stable site-specific (B) Western blot analysis of expression and localization of fusion integration of "antigen cassettes" into the bacterial geproteins. The fusion proteins in the total protein preparations (Total) nome (Shen et al., 1995) . In this study, we constructed and in the secreted protein fractions (Secreted) were detected using a pair of isogenic strains of rLM that express, within a antibodies specific to PhoA (HSL235 and HSL236) and to ha and secreted or nonsecreted dihydrofolate reductase (DHFR) vg (XFL303 and XFL304). 10403S is the parental wild-type strain from which all of the rLM strains are derived. The slight mobility fusion protein, a H-2L d -restricted epitope shift of the fusion proteins between HSL235 and HSL236 reflects the from the nucleoprotein of lymphocytic choriomeningitis addition of NP 118-126 epitope sequence in HSL236, and between virus (LCMV). Strain XFL303 contains an antigen expres-XFL303 and XFL304 the five Hly residues at the N terminus of the sion cassette consisting of NP 118-126 fused to DHFR, mature protein after signal sequence cleavage in XFL303.
the hly promoter, translation initiation and secretory signal sequences. XFL304 is identical to XFL303 except the fusion protein is missing the N-terminal secretion Western blot analysis was used to analyze expression and secretion of fusion proteins. As shown in Figure 1B , signal ( Figure 1A ). Two previously characterized strains, HSL235 and HSL236, were used as a negative and posisimilar amounts of the fusion proteins were present in the total protein preparations as well as in the secreted tive control. HSL236 expresses the LCMV NP 118-126 epitope within a secreted HlyЈ-PhoA fusion and has been fractions of HSL235 and HSL236, indicating that the fusion proteins are synthesized and secreted efficiently shown to induce NP 118-126 specific CD8 T cells (Shen et al., 1995; Slifka et al., 1996) . HSL235 expresses the by these strains. The DHFR fusion proteins were detected in the total protein preparations of XFL303 and same HlyЈ-PhoA fusion as HSL236 but without the NP 118-126 epitope.
XFL304. In the case of XFL303, a similar amount was or XFL304. The same dose response was observed for CD8 T cell responses to two native LM epitopes, LLO 91-99 and p60 217-225 ( Figure 2 ). The magnitude of the responses increased with increasing doses, although it was slightly less pronounced for p60 217-225 and the nonsecreted NP 118-126 than for LLO 91-99 and the secreted NP 118-126 epitopes. When the same immunizing doses were compared, the responses to either of the native LM epitopes were similar in mice immunized with different strains, demonstrating equivalent overall antigen load. Remarkably, the frequency of NP 118-126 specific CD8 T cells induced by the secreted and nonsecreted epitope was also similar. At doses of 1,000 and 5,000 bacteria, there were approximately 2-and 5-fold differences, respectively. Even at the low dose of 300 bacteria, where only a subset of mice had detectable epitope-specific CD8 T cells (1/6 in XFL303 and 2/6 in XFL304 immunized group), the magnitude of the response was only 4-fold lower in the XFL304 immunized mice than in the XFL303 immunized mice. Thus, the nonsecreted bacterial antigen can efficiently prime a CD8 T cell response, even at the suboptimal immunizing dose. We next assessed the establishment of CD8 T cell memory by measuring epitope-specific CD8 T cells at day 60 after immunization with a dose of 1000 bacteria imately 10-fold compared to IFN␥ Elispot assays ( Figure  3 ). Nevertheless, in both assays the relative difference present in the secreted fraction compared to the total in the number of NP 118-126 specific memory CD8 T protein preparation, indicating efficient secretion of the cells between XFL303 and XFL304 immunized mice was fusion protein in this strain. In contrast, no DHFR fusion approximately 3-fold, similar to the ratios observed durwas detectable in the secreted fraction of XFL304 culing the primary response at day 7. Taken together, these tures. This was true even after prolonged exposure of results provide quantitative evidence that a nonsecreted the blot (data not shown). These results demonstrate bacterial antigen, which is not readily accessible by the that comparable amounts of the epitope containing endogenous MHC class I pathway, can prime CD8 T DHFR fusion proteins are made by rLM strains XFL303 cell responses to levels similar to those primed by an and XFL304 and that the DHFR fusion is efficiently seefficiently secreted counterpart. creted from XFL303 while it is exclusively localized within the bacterial cells of XFL304.
Memory CD8 T Cells Induced by Nonsecreted Bacterial Antigens Mount an Effective Nonsecreted Bacterial Antigens Can Efficiently Prime CD8 T Cells In Vivo
In Vivo Anamnestic Response In naive animals the virulent strain of LCMV, clone 13, The isogenic strains XFL303 and XFL304, which differ only in the location of the model antigen, provide an establishes persistent infections characterized by low CD8 T cell responses and high levels of infectious virus experimental system to specifically address the impact of antigen compartmentalization on priming of CD8 T (Ahmed et al., 1984) . In contrast, immune mice mount an accelerated CTL recall response that controls LCMV cells. Balb/c (H-2 d ) mice were immunized with a range of sublethal doses of rLM, and priming of CD8 T cells clone 13 infection (Lau et al., 1994 ). An enhanced secondary response and protection against LCMV chalwas measured by IFN␥ Elispot assays at day 7 after immunization ( Figure 2 ). In mice immunized with approxlenge thus provide in vivo markers for the presence of LCMV epitope-specific memory CD8 T cells induced by imately 100 bacteria, epitope-specific CD8 T cells were below the limit of detection. At a dose of around 300 previous immunization. Two months after immunization with rLM strains, mice bacteria, they were detected sporadically in both XFL303 (secreted NP 118-126) and XFL304 (nonsecreted NP were challenged with LCMV clone 13, and the immune response was analyzed on day 8 post-LCMV infection. 118-126) immunized mice. Increasing the dose to 1,000 or 5,000 bacteria resulted in priming of NP 118-126 speExpansion and activation of total CD8 T cells were measured by flow cytometry analysis after double staining cific CD8 T cells in all mice immunized with either XFL303 Balb/c mice were immunized with the rLM strains and 2 months Balb/c mice (3/group) were immunized with the rLM strains as well later were challenged with LCMV clone 13. Three mice from each as LCMV Armstrong. Two months after immunization, the frequency group were sacrificed on day 8 after LCMV challenge for analysis of NP 118-126 specific CTLp were determined by LDA (A), and the of CD8 T cell responses, and three mice were bled on day 3, 8, 22, number of IFN␥-secreting T lymphocytes (ISL) specific to LCMV NP and 30 to monitor the virus titers in the serum. Data represent 118-126 and two native LM epitopes, LLO 91-99 and p60 217-225, means Ϯ standard deviations. were measured by IFN␥ Elispot assays (B). Data represent means Ϯ (A) Flow cytometry analysis of CD8 T cell expansion/activation. standard deviations.
Spleen cells were stained with antibodies specific to the CD8 molecule and the T cell activation marker, LFA-1. Shown are the profiles of one representative mouse from each group and, for comparison, a naive mouse without LCMV challenge. Profiles of rLM immunized splenocytes for CD8 and LFA-1(CD11a), an adhesion mice before LCMV challenge were very similar to that of the naive molecule that is expressed at higher levels on the sur- tinely seen in naive animals after LCMV clone 13 infec-(D) LCMV titers in the serum of rLM-immunized mice at different tion . In contrast, mice immudays after LCMV challenge. The dotted line indicates the limit of detection.
nized with XFL304, expressing the nonsecreted LCMV epitope, had a much greater increase in the overall percentage of CD8 T cells, and the increase was even more dramatic in the percentage of CD8 T cells with the actiTo assess the NP 118-126 specific CD8 T cell revated (LFA-1 high ) phenotype. Similar results were obsponse, we measured the number of epitope-specific served in mice vaccinated with the isogenic strain CD8 T cells and their direct ex vivo CTL activities at day XFL303 and the positive control HSL236, both of which 8 after LCMV challenge of rLM immunized mice ( Figures  4B and 4C) . In mice immunized with XFL304 expressing secrete the LCMV epitope. the nonsecreted epitope, the frequency of IFN␥ secretnonsecreted bacterial proteins may also serve as protective antigens for CD8 T cell-mediated immunity. To ing lymphocytes specific for NP 118-126 was high (Ͼ10 6 / spleen), 100-fold more than in the negative control test this possibility, we asked if NP 118-126 specific CD8 T cells in LCMV immune mice can provide protection HSL235 immunized mice and comparable to the levels found in mice immunized with the epitope-secreting against rLM expressing a secreted or nonsecreted form of the NP 118-126 epitope. strains XFL303 and HSL236. This frequency represents more than 100-fold expansion of the NP 118-126 specific Balb/c mice were immunized with LCMV Armstrong, which causes an acute infection that is resolved within memory CD8 T cells present before LCMV challenge (about 10 4 /spleen; Figure 3B ). There was minimal lysis a week, resulting in the generation of LCMV-specific memory CTL, the majority (Ͼ95%) of which are specific of NP 118-126 coated targets by splenocytes from the animals immunized with the epitope-negative control to the NP 118-126 epitope (Whitton et al., 1989; van der Most et al., 1996) . At least 5 weeks after infection, the strain HSL235. In contrast, mice immunized with XFL304, expressing the nonsecreted NP 118-126 epitope, had LCMV immune mice and age-matched controls were challenged with a lethal dose ‫01ف(‬ LD50) of the rLM high levels of NP 118-126 specific cytotoxicity, comparable to mice immunized with the isogenic XFL303 and strains, and the number of bacteria in spleen and liver were determined at day 3 after challenge. LCMV immune positive control HSL236 strains. Thus, mice immunized with XFL304 expressing the nonsecreted epitope exhibmice resisted infection with rLM strain HSL236 secreting NP 118-126 as evidenced by a more than 10,000-fold ited an enhanced NP 118-126 specific recall response and total CD8 T cell expansion/activation that was comreduction in the number of bacteria recovered in the spleen and livers of LCMV immune mice compared to parable to mice immunized with XFL303 or HSL236, both of which secrete the epitope. naive mice ( Figure 5A ). This immunity against rLM is specific for the NP 118-126 epitope because LCMV imTo determine whether CD8 T cells elicited in response to a nonsecreted bacterial antigen can provide immunity mune mice fail to resist infection with strain HSL235, which differs from HSL236 only by the absence of the to viral infection, virus titers in serum were measured after LCMV clone 13 challenge of rLM immunized mice.
NP 118-126 epitope. LCMV immune mice also resisted infection by rLM As shown in Figure 4D , mice immunized with the epitope-negative control HSL235 strain had high virus titers strain XFL303, which secretes the LCMV NP 118-126 containing DHFR fusion protein, to a level similar to that throughout the experiment. In contrast, mice immunized with XFL304, expressing the nonsecreted NP 118-126 seen with the positive control strain HSL236 ( Figure 5A ). Thus, memory CD8 T cells specific for a single epitope epitope, controlled viral replication to a similar degree seen in mice immunized with the isogenic strain XFL303 mediate potent immunity against both rLM strains that secrete the epitope containing fusion protein. Strikingly, and the positive control HSL236. The slightly delayed kinetics of viral clearance in XFL304 immunized mice, the LCMV immune mice showed little, if any, specific resistance to rLM strain XFL304 expressing the nonsecompared to mice vaccinated with HSL236 or XFL303, is consistent with the 3-fold lower frequency of NP 118-creted NP 118-126 epitope. When survival was used as readout, all LCMV immune mice infected with 10 5.2 126 specific memory CD8 T cells induced by XFL304 compared to HSL236 or XFL303 immunization (Figures XFL304 died between 4-5 days postinfection. In contrast, 100% of LCMV immune mice survived a dose of 2 and 3). Nevertheless, mice immunized with XFL304 cleared infectious virus by day 30 from serum, whereas 10 6.0 XFL303. These results demonstrate that CD8 T cells specific to nonsecreted antigens are unable to control in the epitope-negative HSL235-immunized mice, LCMV clone 13 established a chronic infection with persistence bacterial infection. Although XFL303 and XFL304 are isogenic strains, it of high virus titers.
In summary, four lines of evidence demonstrate effiis still possible that differences could exist in the ability of these two strains to colonize the host and/or countercient induction of CD8 T cells by a nonsecreted bacterial antigen: priming of NP 118-126 specific CD8 T cells act the immune response. This notion is unlikely because the kinetics of a sublethal infection were compaafter immunization with a rLM expressing a nonsecreted form of NP 118-126 epitope (XFL304); establishment of rable (data not shown), and similar numbers of bacteria NP 118-126 specific memory after immunization with were recovered from the naive control animals after in-XFL304; enhanced recall response after LCMV chalfection with a lethal dose of XFL303 and XFL304 (Figure lenge of XFL304-immunized mice; and protective im-5A). We further addressed this possibility by determining munity against LCMV induced by XFL304 vaccination.
the ability of XFL303 and XFL304 to grow in mice that These results also demonstrate that CD8 T cells induced received LM immune splenocytes. In mice challenged by a nonsecreted bacterial antigen are qualitatively no with either rLM strain, the transferred LM immune different from CD8 T cells induced by its secreted counsplenocytes reduced bacterial loads in spleens by more terpart in that they are all capable of proliferating upon than 4000-fold and in livers by more than 2000-fold com-LCMV challenge and deploying effector functions (i.e., pared to control mice that received PBS ( Figure 5B ). lysis of infected targets and secretion of IFN␥) that conThere was no significant difference between XFL303 trol viral infection.
and XFL304 in the extent to which their growth was limited by LM immune splenocytes. These data demonstrate that the failure of NP 118-126 specific memory Memory CD8 T Cells Specific for the Nonsecreted Antigen Fail to Control Bacterial Infection CTL to control infection with XFL304 is not a consequence of altered virulence or increased ability of this The ability of the nonsecreted epitope to prime CD8 T cell responses efficiently raises the possibility that rLM strain to evade immune defenses. vivo and the ability of CD8 T cells, specific for the same antigen, to mediate protective immunity against bacterial infection. As a first step toward understanding the underling mechanism(s), we tested the hypothesis that nonsecreted bacterial antigens may not be presented in a manner that leads to CTL recognition and killing of LM-infected cells. lysis of XFL304-infected J774 cells by NP 118-126 specific CTL was not due to a lower level of infection because these cells were efficiently lysed by CD8 T cells In summary, we have used the NP 118-126 containing specific to two native LM epitopes, p60 217-225 and DHFR fusion as a model bacterial antigen and demon-LLO 91-99 ( Figures 6B and 6C ), which are secreted by strated that epitope-specific CD8 T cells are able to XFL304. Thus, J774 cells infected with rLM are efficiently control listeriosis caused by bacteria that secrete the lysed by CD8 T cells recognizing the secreted proteins epitope but are unable to confer protection against bacbut not by CD8 T cells directed against the nonsecreted teria that express the same epitope in a nonsecreted model antigen. form. Therefore, compartmentalization of bacterial antigens has a dramatic impact on the ability of memory CD8 T cells to mediate protective immunity against LM Discussion infection.
rLM as a Probe to Investigate Specific Interactions between Intracellular Bacteria LM-Infected Cells Are Not Recognized by CD8 T Cells Specific to the Nonsecreted and the Immune System
The outcome of an infection is the result of a series of Bacterial Antigen The failure of LCMV-specific memory CD8 T cells to complex interactions between the infectious agent and the immune system. Analysis of these interactions reprovide in vivo immunity against XFL304 infection is in direct contrast to the ability of this rLM strain to prime quires an in vivo experimental system in which a single variable can be isolated without disturbing the natural LCMV epitope-specific CD8 T cells effectively. These results provide evidence of a discordance between the interactions between host and pathogen. We have previously described an experimental system that utilizes ability of a bacterial antigen to activate CD8 T cells in rLM-expressing LCMV antigens to study CD8 T cell rePresentation of bacterial antigens by an exogenous sponses and protective immunity (Shen et al., 1995;  pathway to CD8 T cells has been implicated in in vitro Slifka et al., 1996; Jensen et al., 1997) . This system studies using recombinant Escherichia coli and Salmoallows us to manipulate specific aspects of the bactenella typhimurium, organisms, which reside within the rium and then analyze the impact of these changes on phagosome (Pfeifer et al., 1993; Wick et al., 1995) . In the immune response and the course of infection.
contrast, LM gain access to both the phagosome and In this study, we have examined the impact of bacterial cytoplasm of infected cells, and our study of antigen antigen compartmentalization on in vivo priming of CD8 compartmentalization provides an experimental setting T cells and protective immunity. Quantitative analysis in which the same antigen is accessible only by the requires a direct comparison of the same antigen that exogenous pathway in one case (nonsecreted) and is expressed in different bacterial compartments. In this readily available for the endogenous pathway in the approach, selection of a suitable protein antigen beother (secreted). This allows a direct comparison of the comes a critical issue because naturally secreted proefficiency of the two pathways. Our data show that primteins tend to be unstable when localized within the bacing of CD8 T cells in response to the nonsecreted bacteterial cytoplasm, whereas polypeptides that are not rial antigen is remarkably efficient to a level approaching exported naturally are often inefficient in traversing the that of the endogenous pathway for priming of CD8 T bacterial cell membrane (Simonen and Palva, 1993) . We cells against the secreted LM antigen. Recently, several tested several polypeptides, both naturally secreted and groups have argued that the exogenous pathway may nonsecreted, and found that DHFR, a small cytoplasmic play a major role in the initiation of CD8 T cell responses protein, can be efficiently exported by LM and is stable by allowing uninfected phagocytic cells to pick up exogwhen retained within bacterial cells. Using DHFR as a enous antigens and present them to CD8 T cells (Harcarrier protein for a model CD8 T cell epitope, we conding, 1996; Jondal et al., 1996; Rock, 1996) . Phagocytes, structed a pair of isogenic rLM strains that express the such as macrophages and dendritic cells, are profes-LCMV NP 118-126 epitope as part of a secreted or nonsional APC that are potent activators of naive T cells secreted DHFR fusion protein. These isogenic strains as they express high levels of MHC class I, adhesion are identical in every aspect except the localization of receptors, and costimulatory molecules. Although it has the DHFR fusions, thus allowing us to assess precisely been shown that exogenous antigens can elicit a CD8 the influence of bacterial antigen compartmentalization T cell response by cross-priming, this study provides on the CD8 T cell response in vivo.
experimental evidence demonstrating how remarkably Our results show that both the secreted and nonseefficient this pathway can be in vivo. creted forms of the NP 118-126 epitope can efficiently
Analysis of CD8 T cell responses to the recombinant prime CD8 T cells. However, NP 118-126 specific memand native LM epitopes revealed several additional ory CD8 T cells confer protection only against the rLM points of interest. First, expression of the immunodomiexpressing the secreted epitope but not against the nant LCMV NP 118-126 epitope by LM had no marked rLM expressing the nonsecreted epitope. These data effect on CD8 T cell responses to the native LLO or p60 underscore the importance of two distinct issues with bacterial epitopes (Figures 2 and 3) . Second, the NP 118-regard to host immune responses: the question of gen-126 response resulting from immunization with varying erating a specific response, and the question of whether doses of rLM was very similar to that of the native LM the response is protective. Whereas previous work has epitopes, with 300 bacteria being the threshold to induce focused on one or the other independently, our apa detectable response (Figure 2) . Although a previous proach allows us to address both questions with the study has documented protective immunity against LM same antigenic system. Our studies reveal a striking after immunization with 100 bacteria (Barry et al., 1992) , dichotomy between priming of CD8 T cells and protecour results show that at this dose it is not possible to tive immunity as a result of antigen compartmentaldetect CD8 T cell responses to individual epitopes. This ization.
is not surprising because protective immunity against LM is mediated by the concerted action of multiple comIn Vivo Priming of CD8 T Cells by Secreted ponents of the immune system. These include the entire and Nonsecreted Bacterial Antigens repertoire of LM-specific CD8 and CD4 T cells, which Proteins secreted by intracellular LM into the host cell may not individually reach the level detectable by our cytosol are efficiently processed and presented to CD8 assays after low-dose immunization. Nevertheless, it is T cells by the endogenous MHC class I pathway (Vilimportant to note that at a dose of 300 bacteria, the lanueva et al., 1995). Nonsecreted bacterial proteins, same mice that responded to the model NP 118-126 on the other hand, are sequestered by the bacterial epitope also mounted detectable responses to the nacytoplasmic membrane and cell wall. However, it is tive LM epitopes. Thus, the response to our model antiknown that a substantial fraction of LM are destroyed gen is not aberrant but behaves identically to the reby inflammatory neutrophils and macrophages shortly sponse against the native LM antigens. Finally, the after experimental infection (North, 1970; Rogers and frequencies of NP 118-126 specific CD8 T cells after Unanue, 1993) . This destruction occurs in the phagolyrLM immunization were at least 10-fold lower than that sosome prior to LM escape into the cytosol (de Chasinduced by LCMV infection ( Figure 3B ) and were within tellier and Berche, 1994). Thus, bacterial lysis in the the range seen with the two native LM epitopes (Figures phagolysosome provides a mechanism by which nonse-2 and 3). Therefore, the immunodominance of NP 118-creted bacterial proteins can become available for pro-126 that is seen during LCMV infection is not an intrinsic cessing and presentation by an exogenous MHC class I pathway.
property of the peptide but is influenced by the nature late to prevent the progression of LM infection, which includes direct cell-to-cell spread. The above model, however, may not account for all of our observations. The nonsecreted epitope is clearly presented at a level sufficient for priming of naive CD8 T cells. The response to the nonsecreted epitope was only 3-to 5-fold lower than that of the secreted NP 118-126 and was higher than the response to a secreted LM epitope p60 215-227 (Figures 2 and 3) , which elicits CD8 T cells that provide immunity to LM infection (Harty and Pamer, 1995) . In addition, a rLM strain secreting a low level of the NP 118-126 fusion induced a response that was similar to that induced by the nonsecreted epitope, yet this strain was controlled by NP 118-126 specific memory CD8 T cells (Shen et al, unpublished data) . Thus, (Harding, 1996; Jondal et al., 1996; Rock, competition between phagolysosomal fusion and LM escape into 1996), whereas LM infects both phagocytic and non- types, resulting in CD8 T cell recognition of all infected cells and control of listeriosis.
It should be pointed out that the two models are not of the infectious organism that expresses the epitope.
mutually exclusive and both scenarios may occur simulTogether, these observations indicate that the similar taneously in vivo. In principle, both models invoke that priming of CD8 T cells by the secreted and nonsecreted secreted and nonsecreted bacterial proteins are preepitope was not due to saturation of the endogenous sented by the endogenous and exogenous pathways, pathway during rLM infection or due to any unusual respectively, to stimulate a CD8 T cells response. Howproperties of the model epitope.
ever, CTL recognition leading to protective immunity may require antigen presentation by the widely distribThe Dichotomy between Priming of CD8 T Cells uted endogenous pathway. It is also important to point and Protective Immunity as a Result out that these models illustrate a defined aspect of a of Antigen Compartmentalization complex immune response. During LM infection, many Whereas both the secreted and nonsecreted epitope components of the immune system are activated and can efficiently prime a CD8 T cell response, NP 118-126 multiple antigens are recognized by both CD4 and CD8 specific CD8 T cells control infection by rLM secreting T cells. Our ability to specifically manipulate the antigen the epitope but not by rLM expressing the nonsecreted and analyze CD8 T cell responses to a single epitope epitope. These results highlight a divergence between allowed us to achieve a level of resolution that is otherpriming of CD8 T lymphocytes and CD8 T cell-mediated wise not possible. protective immunity ( Figure 7A) Hess et al., 1996; Slifka et al., 1996) . Such spleens and livers as described (Harty and Bevan, 1995) .
effort has, in some cases, been hampered by the inability LCMV stocks were triple plaque purified on Vero cells and grown of bacteria to export some of the foreign antigens effiin BHK-21 cells as described (Ahmed et al., 1984 for CD8 T cell-mediated protective immunity. The rules Infectious virus in serum and tissues was quantitated as described determining which bacterial antigens elicit immune re- (Ahmed et al., 1984) .
sponses and which responses result in protective immuFor adoptive transfer experiment, 5 ϫ 10 7 splenocytes from LMnity are largely unknown. This study uncovers antigen immune Balb/c mice were transferred by intravenous injection into naive Balb/c mice. One hour later, these mice and PBS-injected compartmentalization as one mechanistic reason for controls were challenged with 10 LD50 of rLM strains by intravenous why the response to a particular antigen may not be injection. CFU per spleen and liver were determined 3 days post-rLM protective. This is likely to be a general feature of CD8 infection.
T cell-mediated immunity against infections by intracellular bacteria, fungi, and protozoa. For these complex
Limiting Dilution, IFN␥ Elispot, and CTL Assays pathogens, which express thousands of distinct polyLimiting dilution assays for quantitation of NP 118-126 specific CTLp peptides, focus on the relatively small fraction of sewere carried out as previously described (Lau et al., 1994) . IFN␥-creted antigens would enhance efforts to identify effecsecreting lymphocytes were measured by Elispot assays (Muralitive vaccine antigens for eliciting protective CD8 T cell Krishna et al., 1998 in recent years. As illustrated in this report, combining Direct ex vivo CTL activity was measured using a standard 6 hr the experimental advances in these two fields is a pow-51 Cr release assay (Ahmed et al., 1984) . Target cells are Balb/c clone erful approach, which will provide answers to many ba- 225-specific CD8 T cell lines as previously described (Harty and Bevan, 1995; Harty and Pamer, 1995) .
Experimental Procedures

Flow Cytometry Construction of rLM Strains
Fluorescein isothiocyanate-conjugated rat anti-mouse LFA-1 and DNA sequences encoding DHFR, the hly promoter, and signal sephycoerythrin-conjugated rat anti-mouse CD8a were purchased quence were amplified by PCR from pEH18 (Hurt et al., 1984) and from Pharmingen (San Diego, CA) and used for staining of spleno-LM chromosomal DNA, respectively. Two complementary oligonucytes in PBS containing 1% bovine serum albumin and 0.2% sodium cleotides were synthesized for sequences encoding the NP 118-azide for 30 min at 4ЊC. Analyses were performed on a FACScan 126 epitope (van der Most et al., 1996) and the monoclonal antibody flow cytometer (Becton Dickinson, San Francisco, CA). epitopes, Ha from influenza virus hemoglutinin (Kolodziej and Young, 1991) and Vg from vesicular stomatitis virus glycoprotein (Soldati and Perriard, 1991) . Fusion constructs were assembled by
